Evan Massi

机构：University of California, San Francisco

发表论文 21 篇 · 总被引 440 次 · h-index 4

代表论文

• Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397 (2015 · Cancer Discovery · 被引 211)
• Heterogeneous resistance to quizartinib in acute myeloid leukemia revealed by single-cell analysis (2017 · Blood · 被引 207)
• Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia (2021 · Clinical Cancer Research · 被引 16)
• Recurrent Mutations in CCND3 Confer Clinical Resistance to FLT3 Inhibitors (2015 · Blood · 被引 4)
• Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib (2015 · Leukemia · 被引 2)
• Supplementary Tables 1 - 6, Figures 1 - 7 from Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 “Gatekeeper” F691L Mutation with PLX3397 (2023)